Showing 1881-1890 of 19301 results for "".
Improving Post-Surgical Outcomes With Proactive, Multidisciplinary Care
https://reachmd.com/programs/clinicians-roundtable/improving-post-surgical-outcomes-with-proactive-multidisciplinary-care/36433/Communication breakdowns during care transitions can compromise recovery—but they’re often preventable. Initiating multidisciplinary planning before surgery can help streamline post-surgical wound and skin management. Hear from Dr. Karen Bauer as she explains how how proactive use of care navigaImproving Adherence to Topical Regimens
https://reachmd.com/programs/dermatology-hub-neuroimmune-network/improving-adherence-to-topical-regimens/48780/Zoe Diana Draelos, MD, discusses strategies for improving adherence to topical regimens in chronic atopic dermatitis.Evaluating High- vs. Low-Dose Corticosteroids in Acute IPF Exacerbations
https://reachmd.com/programs/clinicians-roundtable/evaluating-high-vs-low-dose-corticosteroids-in-acute-ipf-exacerbations/35655/A recent study investigated whether pulse-dose corticosteroids offer a benefit over lower doses in managing acute exacerbations of idiopathic pulmonary fibrosis (IPF). Join Dr. Divya Shankar as she explains the real-world data, variability in prescribing patterns, and outcomes observed in differentRethinking Pediatric Atopic Dermatitis: Impacts and Intervention
https://reachmd.com/programs/dermconsult/rethinking-pediatric-atopic-dermatitis-impacts-and-intervention/36440/Emerging research highlights that atopic dermatitis (AD) is a systemic inflammatory disease, not just a skin condition. Left untreated, chronic AD in children can lead to sleep disruption, learning difficulties, psychosocial distress, and impaired quality of life. Discover how timely intervention caConsequences of COVID-19: Addressing Infection-Associated Chronic Conditions
https://reachmd.com/programs/living-rheum/consequences-of-covid-19-addressing-infection-associated-chronic-conditions/32385/Patients experiencing post-acute infectious syndromes have been marginalized, but the advent of long COVID has highlighted their critical needs. Here’s what you should know.The Impact of Climate Change on Infectious Diseases
https://reachmd.com/programs/idsa-action-center/the-impact-of-climate-change-on-infectious-diseases/16103/Is climate change impacting infectious diseases in patients around the world? Read more.ADHD and the Presence of High IQ
https://reachmd.com/programs/clinicians-roundtable/adhd-and-the-presence-of-high-iq/2397/Traditional wisdom says that people with ADHD have lower IQs. Is it possible to have ADHD and a high IQ? Syracuse University psychologist Dr. Kevin Antshel joins host Dr. Leslie Lundt to discuss twice exceptional children.Rebalancing Amyloid in ATTR-CM: Emerging Therapeutic Insights
https://reachmd.com/programs/Audioabstracts/rebalancing-amyloid-attr-cm/49065/While transthyretin amyloid cardiomyopathy (ATTR-CM) is often viewed solely as a disorder of protein misfolding, a new review published in the European Heart Journal presents it as a dynamic imbalance between amyloid production and clearance. Hear from Dr. Hallie Blevins as she reviews pivotal dataGenetic Pathways in MS: The Clinical Impact of a Chromosome 2 Variant
https://reachmd.com/programs/neurofrontiers/genetic-pathways-in-ms-the-clinical-impact-of-a-chromosome-2-variant/32820/In a landmark study involving over 10,000 patients, the International MS Genetics Consortium (IMSGC) has identified the first genetic variant associated with disease severity in multiple sclerosis (MS). Dr. Sergio Baranzini, a Distinguished Professor of Neurology at the University of CalifornNavigating Treatment Goals in IgAN: The Impact of ET-1 and Ang II
https://reachmd.com/programs/clinicians-roundtable/navigating-treatment-goals-in-igan-the-impact-of-et-1-and-ang-ii/37214/Given that the endothelin-1 (ET-1) and angiotensin II (Ang II) pathways contribute to the pathogenesis of IgA nephropathy (IgAN), it’s important to set treatment goals that prevent disease progression. Joining Dr. Charles Turck to discuss the role and impacts of ET-1 and Ang II and how we can achiev